Tag Archives: AI drug discovery

August 6, 2020
In The News

Porcine Reproductive and Respiratory Syndrome (PRRS) virus is the most economically damaging virus for global pork production, responsible for approximately $600 million in annual losses for American pig farmers alone. 

Read Article
August 6, 2020
In The News

Small molecule found to block CD163 surface receptor, which PRRS virus needs to infect pig cells and cause disease.

Read Article
August 6, 2020
In The News

University of Connecticut (UConn) researchers have identified a compound that can successfully block the Porcine Reproductive and Respiratory Syndrome (PRRS) virus. 

Read Article
July 9, 2020
In The News

Drug discovery startup Atomwise and stroke risk predictor Viz.ai are among a group of seven healthcare companies recognized by Forbes for their artificial intelligence capabilities.

Read Article
July 7, 2020
In The News

As Covid-19 continues to threaten lives and livelihoods around the world, a great emphasis has been put on preventing and treating the disease. However, putting a human drug through the FDA approval process costs hundreds of millions of dollars and takes months, if not years, of clinical trials. What if one of the over 7,800 […]

Read Article
July 2, 2020
In The News

The quantity of data about medicines, diseases, and biology is growing. So too, are the number of companies that employ artificial intelligence in drug discovery. Most of the low-hanging fruit in drug research has already been picked, and the industry is clamoring to make sense of the new data, according to Jeffrey Lu, CEO and […]

Read Article